Effect of Case-Management Using Home Monitoring on Diabetes and Blood Pressure Outcomes

NCT ID: NCT00935441

Last Updated: 2011-09-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

460 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-06-30

Study Completion Date

2011-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a randomized trial designed to determine if adoption of the chronic care model in conjunction with nurse case management, home telemonitoring, and home HbA1c monitoring can improve glycemic control compared to patients receiving usual case management. We hypothesize that nurse case management, with home telemonitoring of blood sugars and home HbA1c measurement will result in additional improvements in glycemic control compared to isolated nurse case management. Specifically, the telemonitoring group will have an HbA1c 0.5% lower compared to usual nurse case management. Secondary aims include an additional 5 mmHg improvement in systolic blood pressure (among patients with hypertension at the time of enrollment), improved patient satisfaction with treatment, improved medication adherence, reduced incidence of hypoglycemia, and reduced case manager time in the telemonitoring/home HbA1c group compared with usual caes management. The study will enroll 460 diabetic patients with HbA1c values greater than 8.5%, age 75 years or younger, who have a active land-line for telephone communication. Patients will be enrolled and actively case managed for 9 months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Telemonitoring

Case management with home telemonitoring for blood sugar and blood pressure plus home HbA1c measurement

Group Type EXPERIMENTAL

case management with telemonitoring

Intervention Type BEHAVIORAL

telephone contact with a case manager, home telemonitoring equipment for blood sugar and blood pressure, home HbA1c measurement

Usual case management

Case management

Group Type ACTIVE_COMPARATOR

usual case management

Intervention Type BEHAVIORAL

telephone contact with a case manager

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

case management with telemonitoring

telephone contact with a case manager, home telemonitoring equipment for blood sugar and blood pressure, home HbA1c measurement

Intervention Type BEHAVIORAL

usual case management

telephone contact with a case manager

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Enrolled at Minneapolis VAMC,
* Type 1 or 2 Diabetes,
* HbA1c \>8.5%,
* active land-line telephone connection

Exclusion Criteria

* Age \>75 years,
* primary care provider unwilling to have patient enrolled,
* active dialysis,
* resident of assisted living facility,
* research participant in previous diabetes case management study,
* life expectancy \<1 year,
* severe mental health condition,
* active substance abuse,
* pregnant or planning on becoming pregnant
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Minneapolis Veterans Affairs Medical Center

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nacide Ercan-Fang

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Minneapolis VAMC

Minneapolis, Minnesota, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

4127-B

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Proactive Diabetes Case Management
NCT00013208 COMPLETED NA
The Diabetes TeleCare Study
NCT00288132 COMPLETED NA